OneMedNet stockholders back equity plan increase and possible reverse stock split
At its September 18, 2026 annual meeting, OneMedNet shareholders approved director elections, an auditor ratification, an expanded equity incentive plan, and authority for a reverse stock split of between 1-for-5.
OneMedNet Corporation disclosed in an 8-K filing that it held its 2026 Annual Meeting of Stockholders on September 18, 2026, conducted as a virtual meeting with a live audio webcast, where stockholders approved an amended and restated version of the company's 2022 Equity Incentive Plan.1 The amendment raises the number of shares authorized under the plan by 1,000,000 shares and took effect immediately once stockholders approved it at the meeting.1
The filing states that 41,841,452 votes were represented at the meeting, either in person or by proxy, equal to 70.57% of votes entitled to be cast, enough for a quorum.1
Stockholders voted on four proposals. In the first, three Class III director nominees, Dr. Kenneth Alleyne, Sherry Coonse McCraw, and Dr. Jeffrey Yu, were elected to three-year terms running through the company's 2029 Annual Meeting.1
The second proposal covered the company's outside auditor. Stockholders ratified WithumSmith+Brown, PC to continue as OneMedNet's independent registered public accounting firm for fiscal year 2026.1
The third proposal was the equity plan change described above, and the fourth authorized a possible capital structure move. Stockholders approved an amendment to the company's certificate of incorporation allowing a reverse stock split at a ratio to be selected by the board, anywhere from 1-for-5 up to 1-for-20.1
The filing was signed by Chief Executive Officer Aaron Green and dated September 23, 2026. The full text of the amended equity plan was filed as an exhibit to the report.
Written by readthrough’s AI from the linked primary sources and fact-checked against them automatically before publishing. Not investment advice.